Koulong Zheng - Publications

CCR5 and CD74 are potential therapeutic targets for necroinflammation in preclinical cholesterol crystal embolism.

Journal: Science translational medicine

Published: May 27, 2026

Exosomes in organ transplantation: roles in immunomodulation, ferroptosis and mitophagy.

Journal: Frontiers in immunology

Published: October 15, 2025

Clinically validated immune-related gene markers and molecular subtypes in acute myocardial infarction revealed by peripheral blood transcriptomics.

Journal: Frontiers in cardiovascular medicine

Published: June 10, 2025

Distribution Patterns of Paroxysmal Atrial Fibrillation Triggers and Catheter Ablation Success Rates.

Journal: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc

Published: November 15, 2024

Nomogram for predicting cardiovascular mortality in patients with gastrointestinal stromal tumor: A population-based study.

Journal: Medicine

Published: September 27, 2024

Application of AI-empowered scenario-based simulation teaching mode in cardiovascular disease education.

Journal: BMC medical education

Published: February 15, 2024

Reply to "Loganin: A potential pharmacological agent for myocardial ischemia-reperfusion injury".

Journal: International journal of cardiology

Published: December 17, 2023

L-theanine alleviates myocardial ischemia/reperfusion injury by suppressing oxidative stress and apoptosis through activation of the JAK2/STAT3 pathway in mice.

Journal: Molecular medicine (Cambridge, Mass.)

Published: October 22, 2023

Loganin protects against myocardial ischemia-reperfusion injury by modulating oxidative stress and cellular apoptosis via activation of JAK2/STAT3 signaling.

Journal: International journal of cardiology

Published: April 01, 2023

Down-regulation of Hrd1 protects against myocardial ischemia-reperfusion injury by regulating PPARα to prevent oxidative stress, endoplasmic reticulum stress, and cellular apoptosis.

Journal: European journal of pharmacology

Published: March 07, 2023

The value of serum Sema4D level in predicting the prognosis of patients with acute ST-segment elevation myocardial infarction and with high thrombus burden.

Journal: BMC cardiovascular disorders

Published: January 26, 2023

The value of serum Sema4D level in reflecting the inflammatory state of acute ST-segment elevation myocardial infarction.

Journal: Journal of thoracic disease

Published: November 22, 2022